লোডিং...
Comparing safety information of biosimilars with their originators: a cross‐sectional analysis of European risk management plans
BACKGROUND AND AIMS: Biosimilars have been available in the European Union (EU) since 2006. However, their uptake in routine care is heterogeneous across countries. The aim of the present study was to compare the safety information of biosimilars and their originators based on the information in the...
সংরক্ষণ করুন:
| প্রকাশিত: | Br J Clin Pharmacol |
|---|---|
| প্রধান লেখক: | , , , , , , , , |
| বিন্যাস: | Artigo |
| ভাষা: | Inglês |
| প্রকাশিত: |
John Wiley and Sons Inc.
2018
|
| বিষয়গুলি: | |
| অনলাইন ব্যবহার করুন: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5867080/ https://ncbi.nlm.nih.gov/pubmed/29164665 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13454 |
| ট্যাগগুলো: |
ট্যাগ যুক্ত করুন
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|